Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Health Care REITs Industry Analysis

UpdatedDec 15, 2025
DataAggregated Company Financials
Companies19
  • 7D-6.0%
  • 3M4.1%
  • 1Y22.2%
  • YTD26.9%

Over the last 7 days, the Health Care REITs industry has dropped 6.0%, driven by Welltower declining 7.0%. Over the past 12 months, the industry was up 22%. As for the next few years, earnings are expected to grow by 32% per annum.

Industry Valuation and Performance

Has the U.S. Health Care REITs Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 16 Dec 2025US$239.0bUS$31.5bUS$440.3m32.4x542.9x7.6x
Thu, 13 Nov 2025US$245.1bUS$31.5bUS$460.1m31x532.8x7.8x
Sat, 11 Oct 2025US$218.9bUS$30.4bUS$354.3m30.2x618x7.2x
Mon, 08 Sep 2025US$223.0bUS$30.4bUS$354.3m33.3x629.4x7.3x
Wed, 06 Aug 2025US$217.3bUS$30.8bUS$168.7m34.7x1288.1x7x
Fri, 04 Jul 2025US$200.5bUS$29.4bUS$68.9m37x2911x6.8x
Sun, 01 Jun 2025US$197.7bUS$29.7bUS$181.8m31.8x1087.4x6.7x
Tue, 29 Apr 2025US$196.0bUS$28.8b-US$1,032,275,000.0033.3x-189.8x6.8x
Thu, 27 Mar 2025US$200.7bUS$28.7b-US$1,068,162,000.0034.5x-187.9x7x
Sat, 22 Feb 2025US$196.2bUS$28.1b-US$1,436,327,000.0033.7x-136.6x7x
Mon, 20 Jan 2025US$179.3bUS$27.4b-US$1,625,663,000.0041.2x-110.3x6.6x
Wed, 18 Dec 2024US$180.3bUS$27.4b-US$1,625,663,000.0043x-110.9x6.6x
Fri, 15 Nov 2024US$190.2bUS$27.4b-US$1,625,662,000.0044.4x-117x7x
Sun, 13 Oct 2024US$182.3bUS$26.2b-US$1,429,354,000.0053.7x-127.6x7x
Tue, 10 Sep 2024US$182.8bUS$26.2b-US$1,429,354,000.0053.4x-127.9x7x
Thu, 08 Aug 2024US$168.3bUS$26.6b-US$1,105,766,000.0051x-152.2x6.3x
Sat, 06 Jul 2024US$154.0bUS$26.1b-US$1,195,454,000.0044.6x-128.8x5.9x
Mon, 03 Jun 2024US$152.6bUS$26.1b-US$1,195,454,000.0042.3x-127.6x5.9x
Wed, 01 May 2024US$120.5bUS$22.9b-US$294,520,000.0041.9x-409.1x5.3x
Fri, 29 Mar 2024US$116.7bUS$22.6b-US$276,709,000.0041.8x-421.8x5.2x
Sun, 25 Feb 2024US$115.5bUS$23.0b-US$277,711,000.0035.9x-416x5x
Tue, 23 Jan 2024US$114.4bUS$22.9bUS$87.5m45.1x1307.7x5x
Thu, 21 Dec 2023US$118.1bUS$22.9bUS$87.5m45.5x1350x5.2x
Sat, 18 Nov 2023US$109.6bUS$22.9bUS$87.5m39.9x1252.7x4.8x
Mon, 16 Oct 2023US$106.7bUS$22.6bUS$502.0m29x212.6x4.7x
Wed, 13 Sep 2023US$108.9bUS$22.6bUS$511.5m33x212.9x4.8x
Fri, 11 Aug 2023US$112.8bUS$22.6bUS$575.9m35.4x195.9x5x
Sun, 09 Jul 2023US$109.8bUS$22.0bUS$785.0m32.6x139.9x5x
Tue, 06 Jun 2023US$105.4bUS$21.8bUS$840.1m30.8x125.5x4.8x
Thu, 04 May 2023US$106.2bUS$21.4bUS$1.3b30.5x84.3x5x
Sat, 01 Apr 2023US$102.5bUS$21.2bUS$2.0b32.6x51.4x4.8x
Price to Earnings Ratio

51.4x


Total Market Cap: US$102.5bTotal Earnings: US$2.0bTotal Revenue: US$21.2bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Health Care REITs Industry Price to Earnings3Y Average 321.5x20242025
Current Industry PE
  • Investors are optimistic on the American Health Care REITs industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 543x which is higher than its 3-year average PE of 321x.
  • The 3-year average PS ratio of 6.0x is lower than the industry's current PS ratio of 7.6x.
Past Earnings Growth
  • The earnings for companies in the Health Care REITs industry have declined 40% per year over the last three years.
  • Meanwhile revenues for these companies have grown 14% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the U.S. Real Estate industry?

US Market-0.59%
Real Estate-0.74%
Health Care REITs-5.96%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ARE Alexandria Real Estate EquitiesUS$47.415.4%
+US$421.7m		-53.2%PB0.5x
HR Healthcare Realty TrustUS$17.230.9%
+US$56.3m		-0.6%PB1.3x
SILA Sila Realty TrustUS$23.123.5%
+US$43.0m		-9.3%PB0.9x
DHC Diversified Healthcare TrustUS$4.913.2%
+US$36.3m		100.4%PB0.7x
GMRE Global Medical REITUS$35.247.3%
+US$32.2m		-16.1%PB1.2x

Latest News

DOC
US$16.66
Healthpeak Properties
7D
-0.5%
1Y
-19.6%

DOC: Share Repurchases And Margin Outlook Will Support Future Upside Potential

Analysts have trimmed their price target on Healthpeak Properties to approximately $26.65 from about $27.73, reflecting slightly higher discount-rate assumptions and more modest revenue growth expectations, partially offset by improved profit margin and a lower projected future price to earnings multiple. What's in the News Completed repurchase of 5,091,156 shares for approximately $94.17 million under the buyback program announced on July 25, 2024, representing about 0.73% of shares (Key Developments) No additional shares were repurchased between July 1, 2025 and September 30, 2025 under the existing buyback tranche, with total spending of $0 million in the period (Key Developments) Removed from the FTSE All-World Index (USD), which may affect index-linked ownership and trading volumes for the stock (Key Developments) Valuation Changes Fair Value Estimate decreased slightly to approximately $26.65 from about $27.73.
OHI
US$44.54
Omega Healthcare Investors
7D
-2.5%
1Y
14.2%

OHI: Future Investment Activity And Dividend Consistency Will Drive Measured Upside Potential

The analyst price target for Omega Healthcare Investors has been raised modestly from approximately $45.94 to $46.56 per share, as analysts cite stronger expected investment volumes, a broad addressable market, and resilient REIT earnings as support for higher long term revenue growth and margins. Analyst Commentary Recent Street research reflects a generally constructive view on Omega Healthcare Investors, with multiple firms lifting price targets into the mid to high $40s and several anchoring on upside scenarios that reach $50 per share.
UHT
US$42.22
Universal Health Realty Income Trust
7D
4.2%
1Y
9.8%
CHCT
US$15.49
Community Healthcare Trust
7D
1.9%
1Y
-15.6%

CHCT: Rising Quarterly Dividend Will Support Attractive Future Total Returns

Analysts have modestly reiterated their view on Community Healthcare Trust, keeping the price target effectively unchanged at approximately $17.80 per share, as slightly lower discount rate assumptions offset stable growth and margin expectations. What's in the News The Board of Directors approved an increase in the common stock cash dividend for the quarter ended September 30, 2025 to 0.475 dollars per share, payable November 21, 2025 to shareholders of record on November 7, 2025 (Key Developments) The new quarterly dividend rate represents an annualized dividend of 1.90 dollars per share, which may enhance the stock's income profile for investors (Key Developments) Community Healthcare Trust has raised its dividend every quarter since its Initial Public Offering, highlighting a multiyear track record of consistent dividend growth (Key Developments) Valuation Changes Fair Value: Remains unchanged at approximately $17.80 per share, indicating no revision to the intrinsic value estimate.
VTR
US$78.71
Ventas
7D
-2.8%
1Y
32.3%

VTR: Full Year 2025 Guidance Will Support Improved Profitability Outlook

Analysts have modestly raised their price target on Ventas from 82.95 dollars to 84.70 dollars, citing slightly faster anticipated revenue growth, marginally improved profit margins, and a lower discount rate that together support a higher future earnings multiple. What's in the News Ventas raised its full year 2025 earnings guidance, now expecting attributable net income per share of 0.49 to 0.52 dollars, up from the prior range of 0.47 to 0.52 dollars (company guidance) Valuation Changes Fair Value Estimate has risen slightly to 84.70 dollars from 82.95 dollars, reflecting a modestly higher intrinsic valuation.
NHI
US$78.03
National Health Investors
7D
-1.0%
1Y
9.2%
DHC
US$4.91
Diversified Healthcare Trust
7D
3.2%
1Y
100.4%

DHC: Improved Capital Flexibility Will Drive Repricing Despite Higher Interest Costs

The analyst price target for Diversified Healthcare Trust has been raised from $4.50 to $5.50 per share, as analysts point to improved capital flexibility and more favorable growth and valuation assumptions that outweigh modest margin and interest headwinds. Analyst Commentary Bullish analysts have recently highlighted a more constructive outlook on Diversified Healthcare Trust, reflecting growing confidence in the company’s balance sheet, earnings trajectory, and ability to execute on its strategic priorities.
GMRE
US$35.24
Global Medical REIT
7D
7.3%
1Y
-16.1%

GMRE: Reverse Split And Higher Multiple Will Support Stronger Future Upside

Analysts have raised their price target on Global Medical REIT from approximately $12 to about $57 per share, citing an updated fair value assessment that offsets modestly lower revenue growth and profit margin expectations, along with a slightly richer future earnings multiple. What's in the News Global Medical REIT amended its charter under Maryland law to implement a 1 for 5 reverse stock split, consolidating every five existing common shares into one new share with a par value of $0.005.
WELL
US$190.47
Welltower
7D
-5.2%
1Y
48.0%
ARE
US$47.41
Alexandria Real Estate Equities
7D
5.4%
1Y
-53.2%

ARE Dividend Reset And Buyback Will Support Long Term Recovery

Analysts have trimmed their price target for Alexandria Real Estate Equities by roughly 8 percent to about $63 per share, citing higher perceived risk, weaker projected revenue growth, and sharply compressed profit margins. Together, these factors are seen as warranting a lower fair value multiple.
AHR
US$47.20
American Healthcare REIT
7D
-5.3%
1Y
67.6%

AHR: Follow-On Equity Offering Will Support Future Upside Potential

Analysts have slightly lowered their price target on American Healthcare REIT to approximately $56.08 per share from about $56.08 per share, reflecting marginally reduced discount rate and future P/E assumptions while maintaining largely unchanged growth and profitability expectations. What's in the News Completed a follow on equity offering of 8,100,000 common shares at $47.75 per share, raising approximately $386.8 million, with the securities structured as an income trust (Key Developments) Filed a follow on equity offering for 8,100,000 shares of common stock, signaling plans to access additional equity capital (Key Developments) Recorded consolidated impairment charges of $3.8 million on real estate investments for the quarter ended September 30, 2025, reflecting write downs on certain properties (Key Developments) Raised full year 2025 guidance, increasing expected diluted EPS to $0.47 to $0.50, same store NOI growth to 13.0 to 15.0 percent, and net income attributable to common stockholders to $78 million to $83 million (Key Developments) Valuation Changes Fair Value Estimate remains unchanged at approximately $56.08 per share, indicating no revision to the intrinsic value assessment.
STRW
US$13.90
Strawberry Fields REIT
7D
10.3%
1Y
37.2%
MPW
US$5.04
Medical Properties Trust
7D
-8.0%
1Y
29.2%

MPW: Future Performance Will Reflect Incremental Improvements Amid Ongoing Balance Sheet And Margin Risks

The analyst price target for Medical Properties Trust has been raised by $0.50 to $4.50 as analysts factor in slightly stronger sector level earnings resilience, modestly higher long term revenue growth and a lower discount rate, even as margin expectations edge down. Analyst Commentary Recent commentary on Medical Properties Trust highlights a mixed but more constructive tone around the stock, with the latest target price revision reflecting incremental improvements in fundamentals and sector sentiment rather than a wholesale change in thesis.
CTRE
US$36.59
CareTrust REIT
7D
-3.0%
1Y
27.8%

CTRE: Future Performance Will Reflect Skilled Nursing Exposure And International Expansion

Analysts have raised their price target for CareTrust REIT from $38.44 to $39.55, citing anticipated positive estimate revisions due to stronger investment volumes and robust rent coverage in skilled nursing facilities. Analyst Commentary Recent analyst coverage has focused on CareTrust REIT's outlook and valuation following its adjusted price target.
HR
US$17.23
Healthcare Realty Trust
7D
0.9%
1Y
-0.6%

HR: Share Buybacks And Earnings Outlook Will Shape A Measured Path Forward

Healthcare Realty Trust’s average analyst price target has edged slightly higher from $19.30 to $19.50. Analysts attribute this change to modest adjustments in valuation assumptions and outlook.
SILA
US$23.12
Sila Realty Trust
7D
3.5%
1Y
-9.3%